Last week, the crowdfunding campaign reached the objective of 100,000 € with the contribution of 41 investors. The funding is devoted to the schizophrenia project, where a cognitive enhancer has been discovered. Preclinical experiments will be finished with the money raised. Afterwards, the drug will enter into clinical phase I. We want to thank them all investors for their support in the Iproteos project!